MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 142 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $324,000 | -87.7% | 2,222 | -80.5% | 0.00% | -100.0% |
| Q2 2023 | $2,630,000 | -16.3% | 11,388 | -12.2% | 0.00% | 0.0% |
| Q1 2023 | $3,143,000 | -17.7% | 12,971 | -1.4% | 0.00% | 0.0% |
| Q4 2022 | $3,817,000 | +454.8% | 13,150 | +24.3% | 0.00% | – |
| Q3 2022 | $688,000 | -8.4% | 10,580 | +0.8% | 0.00% | – |
| Q2 2022 | $751,000 | -31.4% | 10,497 | -5.8% | 0.00% | – |
| Q1 2022 | $1,094,000 | -1.4% | 11,149 | -15.0% | 0.00% | – |
| Q4 2021 | $1,110,000 | +76.5% | 13,110 | +66.5% | 0.00% | – |
| Q3 2021 | $629,000 | -16.2% | 7,873 | +2.3% | 0.00% | – |
| Q2 2021 | $751,000 | +1646.5% | 7,699 | +1997.8% | 0.00% | – |
| Q1 2021 | $43,000 | +168.8% | 367 | +154.9% | 0.00% | – |
| Q4 2020 | $16,000 | +6.7% | 144 | +14.3% | 0.00% | – |
| Q3 2020 | $15,000 | +114.3% | 126 | +106.6% | 0.00% | – |
| Q2 2020 | $7,000 | +16.7% | 61 | -32.2% | 0.00% | – |
| Q1 2020 | $6,000 | -81.8% | 90 | -74.6% | 0.00% | – |
| Q4 2019 | $33,000 | +312.5% | 355 | +285.9% | 0.00% | – |
| Q3 2019 | $8,000 | -20.0% | 92 | 0.0% | 0.00% | – |
| Q2 2019 | $10,000 | -33.3% | 92 | -24.6% | 0.00% | – |
| Q1 2019 | $15,000 | 0.0% | 122 | -8.3% | 0.00% | – |
| Q4 2018 | $15,000 | -81.9% | 133 | -66.0% | 0.00% | – |
| Q3 2018 | $83,000 | -96.8% | 391 | -95.8% | 0.00% | -100.0% |
| Q2 2018 | $2,598,000 | +139.0% | 9,291 | -0.1% | 0.00% | – |
| Q1 2018 | $1,087,000 | +26.0% | 9,304 | -1.0% | 0.00% | – |
| Q4 2017 | $863,000 | +100.7% | 9,401 | -1.6% | 0.00% | – |
| Q3 2017 | $430,000 | +14233.3% | 9,553 | +5008.6% | 0.00% | – |
| Q2 2017 | $3,000 | +200.0% | 187 | +315.6% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 45 | +7.1% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 42 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | – | 42 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
| L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
| Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
| Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
| ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
| Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
| Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
| Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |